Literature DB >> 20631095

Emergence and localized circulation of a vaccine-derived poliovirus in an isolated mountain community in Guangxi, China.

Dongmei Yan1, Li Li, Shuangli Zhu, Yong Zhang, Junjing An, Dongyan Wang, Ning Wen, Jaume Jorba, Wei Liu, Ge Zhong, Lin Huang, Olen Kew, Xiaofeng Liang, Wenbo Xu.   

Abstract

From March to May 2006, type 1 circulating vaccine-derived poliovirus (cVDPV) was isolated from one case patient with acute flaccid paralysis (AFP) and six unimmunized healthy contacts in isolated mountain villages in Guangxi, China. We conducted epidemiological investigations in the affected communities and nucleotide sequence analyses of the cVDPV isolates. The results of the investigations showed that the AFP patient, an unimmunized 10-year-old boy, and five laboratory-confirmed contacts lived in the same village; one contact lived in a neighboring village. Only approximately 27% of children 5 to 10 years of age in the affected villages had received three or more doses of the trivalent oral poliovirus vaccine (OPV). Nucleotide sequence analyses revealed that the cVDPV isolates differed from the Sabin 1 (S1) isolate at 1.4 to 2.2% of VP1 nucleotide positions and shared 12 nucleotide substitutions within VP1. All isolates were S1/S2/S1/S3 recombinants sharing common recombination junctions. Key determinants of attenuation were replaced. Phylogenetic analysis suggested that the cVDPV circulated locally for approximately 12 months following the initiating OPV dose. No VDPVs were found after mass OPV immunizations, conducted from May to June 2006, that targeted all children <12 years of age. Our findings reinforce the point that VDPVs can emerge and spread in isolated communities with immunity gaps. Maintenance of sensitive AFP and poliovirus surveillance is essential to permit early detection and a rapid response to VDPV circulation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20631095      PMCID: PMC2937699          DOI: 10.1128/JCM.00712-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  39 in total

1.  Multiplex PCR method for identifying recombinant vaccine-related polioviruses.

Authors:  David R Kilpatrick; Karen Ching; Jane Iber; Ray Campagnoli; Christopher J Freeman; Nada Mishrik; Hong-Mei Liu; Mark A Pallansch; Olen M Kew
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

2.  The natural genomic variability of poliovirus analyzed by a restriction fragment length polymorphism assay.

Authors:  J Balanant; S Guillot; A Candrea; F Delpeyroux; R Crainic
Journal:  Virology       Date:  1991-10       Impact factor: 3.616

3.  Mutations conferring resistance to neutralization with monoclonal antibodies in type 1 poliovirus can be located outside or inside the antibody-binding site.

Authors:  B Blondel; R Crainic; O Fichot; G Dufraisse; A Candrea; D Diamond; M Girard; F Horaud
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

Review 4.  Antigenic structure of picornaviruses.

Authors:  P D Minor
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

5.  Three-dimensional structure of poliovirus serotype 1 neutralizing determinants.

Authors:  G S Page; A G Mosser; J M Hogle; D J Filman; R R Rueckert; M Chow
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

6.  Evidence for a complex structure of neutralization antigenic site I of poliovirus type 1 Mahoney.

Authors:  K Wiegers; H Uhlig; R Dernick
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

7.  Studies of the immunogenicity, communicability and genetic stability of oral poliovaccine administered during the winter.

Authors:  M Benyesh-Melnick; J L Melnick; W E Rawls; I Wimberly; J B Oro; E Ben-Porath; V Rennick
Journal:  Am J Epidemiol       Date:  1967-07       Impact factor: 4.897

8.  Unbiased estimation of the rates of synonymous and nonsynonymous substitution.

Authors:  W H Li
Journal:  J Mol Evol       Date:  1993-01       Impact factor: 2.395

Review 9.  The epidemiology of poliomyelitis: enigmas surrounding its appearance, epidemicity, and disappearance.

Authors:  N Nathanson; J R Martin
Journal:  Am J Epidemiol       Date:  1979-12       Impact factor: 4.897

10.  Evolution of the Zfx and Zfy genes: rates and interdependence between the genes.

Authors:  P Pamilo; N O Bianchi
Journal:  Mol Biol Evol       Date:  1993-03       Impact factor: 16.240

View more
  11 in total

1.  Limited and localized outbreak of newly emergent type 2 vaccine-derived poliovirus in Sichuan, China.

Authors:  Dongmei Yan; Yong Zhang; Shuangli Zhu; Na Chen; Xiaolei Li; Dongyan Wang; Xiaozhen Ma; Hui Zhu; Wenbin Tong; Wenbo Xu
Journal:  Clin Vaccine Immunol       Date:  2014-05-21

2.  Oral poliovirus vaccine evolution and insights relevant to modeling the risks of circulating vaccine-derived polioviruses (cVDPVs).

Authors:  Radboud J Duintjer Tebbens; Mark A Pallansch; Jong-Hoon Kim; Cara C Burns; Olen M Kew; M Steven Oberste; Ousmane M Diop; Steven G F Wassilak; Stephen L Cochi; Kimberly M Thompson
Journal:  Risk Anal       Date:  2013-03-07       Impact factor: 4.000

3.  Identification of vaccine-derived polioviruses using dual-stage real-time RT-PCR.

Authors:  David R Kilpatrick; Karen Ching; Jane Iber; Qi Chen; Su-Ju Yang; Lina De; A J Williams; Mark Mandelbaum; Hong Sun; M Steven Oberste; Olen M Kew
Journal:  J Virol Methods       Date:  2013-12-07       Impact factor: 2.014

4.  Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern Nigeria.

Authors:  Cara C Burns; Jing Shaw; Jaume Jorba; David Bukbuk; Festus Adu; Nicksy Gumede; Muhammed Ali Pate; Emmanuel Ade Abanida; Alex Gasasira; Jane Iber; Qi Chen; Annelet Vincent; Paul Chenoweth; Elizabeth Henderson; Kathleen Wannemuehler; Asif Naeem; Rifqiyah Nur Umami; Yorihiro Nishimura; Hiroyuki Shimizu; Marycelin Baba; Adekunle Adeniji; A J Williams; David R Kilpatrick; M Steven Oberste; Steven G Wassilak; Oyewale Tomori; Mark A Pallansch; Olen Kew
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

5.  Circulation of multiple serotypes of highly divergent enterovirus C in the Xinjiang Uighur Autonomous Region of China.

Authors:  Yong Zhang; Qiang Sun; Hui Cui; Dongmei Yan; Qin Fan; Yang Song; Shuangli Zhu; Xiaolei Li; Guohong Huang; Tianjiao Ji; Lan Hu; Dongyan Wang; Qian Yang; Wenbo Xu
Journal:  Sci Rep       Date:  2016-09-19       Impact factor: 4.379

6.  A Large-Scale Outbreak of Echovirus 30 in Gansu Province of China in 2015 and Its Phylodynamic Characterization.

Authors:  Jianhua Chen; Zhenzhi Han; Haizhuo Wu; Wenbo Xu; Deshan Yu; Yong Zhang
Journal:  Front Microbiol       Date:  2020-06-10       Impact factor: 5.640

7.  Circulation of Type 2 Vaccine-Derived Poliovirus in China in 2018-2019.

Authors:  Hehe Zhao; Xiaozhen Ma; Haishu Tang; Yong Zhang; Na Chen; Wusiman Kaisaier; Qi Wang; Cheng Wang; Shuangli Zhu; Qi Qi; Yu Liu; Qianli Ma; Qing Yang; Junhan Li; Dongyan Wang; Xiaolei Li; Jinbo Xiao; Hui Zhu; Wenbo Xu; Wenbin Tong; Dongmei Yan
Journal:  Open Forum Infect Dis       Date:  2021-10-17       Impact factor: 3.835

8.  Emergence of vaccine-derived polioviruses, Democratic Republic of Congo, 2004-2011.

Authors:  Nicksy Gumede; Olivia Lentsoane; Cara C Burns; Mark Pallansch; Esther de Gourville; Riziki Yogolelo; Jean Jacques Muyembe-Tamfum; Adrian Puren; Barry D Schoub; Marietjie Venter
Journal:  Emerg Infect Dis       Date:  2013-10       Impact factor: 6.883

9.  An Insight into Recombination with Enterovirus Species C and Nucleotide G-480 Reversion from the Viewpoint of Neurovirulence of Vaccine-Derived Polioviruses.

Authors:  Yong Zhang; Dongmei Yan; Shuangli Zhu; Yorihiro Nishimura; Xufang Ye; Dongyan Wang; Jaume Jorba; Hui Zhu; Hongqiu An; Hiroyuki Shimizu; Olen Kew; Wenbo Xu
Journal:  Sci Rep       Date:  2015-11-25       Impact factor: 4.379

10.  Vaccine-derived poliovirus surveillance in China during 2001-2013: the potential challenge for maintaining polio free status.

Authors:  Hai-Bo Wang; Hui-Ming Luo; Li Li; Chun-Xiang Fan; Li-Xin Hao; Chao Ma; Qi-Ru Su; Hong Yang; Kathleen H Reilly; Hua-Qing Wang; Ning Wen
Journal:  BMC Infect Dis       Date:  2017-12-02       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.